Profiles Header - Harvard Catalyst Profiles Header – Harvard Catalyst

Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joji Suzuki, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Weiner SG, Price CN, Atalay AJ, Harry EM, Pabo EA, Patel R, Suzuki J, Anderson S, Ashley SW, Kachalia A. A Health System-Wide Initiative to Decrease Opioid-Related Morbidity and Mortality. Jt Comm J Qual Patient Saf. 2018 Aug 28. PMID: 30166254.
    View in: PubMed
  2. Suzuki J, Johnson J, Montgomery M, Hayden M, Price C. Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature. Open Forum Infect Dis. 2018 Sep; 5(9):ofy194. PMID: 30211247.
    View in: PubMed
  3. Braun IM, Wright A, Peteet J, Meyer FL, Yuppa DP, Bolcic-Jankovic D, LeBlanc J, Chang Y, Yu L, Nayak MM, Tulsky JA, Suzuki J, Nabati L, Campbell EG. Medical Oncologists' Beliefs, Practices, and Knowledge Regarding Marijuana Used Therapeutically: A Nationally Representative Survey Study. J Clin Oncol. 2018 Jul 01; 36(19):1957-1962. PMID: 29746226.
    View in: PubMed
  4. Suzuki J, Garayalde S, Dodoo M, Rodriguez C. Psychiatry residents' and fellows' confidence and knowledge in interpreting urine drug testing results related to opioids. Subst Abus. 2018 Apr 26; 1-4. PMID: 29697313.
    View in: PubMed
  5. Friedmann PD, Suzuki J. More beds are not the answer: transforming detoxification units into medication induction centers to address the opioid epidemic. Addict Sci Clin Pract. 2017 11 15; 12(1):29. PMID: 29141667.
    View in: PubMed
  6. Suzuki J, Zinser J, Issa M, Rodriguez C. Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment. Subst Abus. 2017 Oct-Dec; 38(4):504-507. PMID: 28723256.
    View in: PubMed
  7. Twark C, Suzuki J. Fenethylline-Induced Psychosis, Fenethylline-Themed Paranoid Delusions, or Both? Psychosomatics. 2017 Sep - Oct; 58(5):561-564. PMID: 28577859.
    View in: PubMed
  8. Braun IM, Meyer FL, Gagne JJ, Nabati L, Yuppa DP, Carmona MA, Burstein HJ, Suzuki J, Nayak MM, Martins Y. Experts' perspectives on the role of medical marijuana in oncology: A semistructured interview study. Psychooncology. 2017 08; 26(8):1087-1092. PMID: 28040884.
    View in: PubMed
  9. Suzuki J, Valenti ES. Intentional Intra-arterial Injection of Heroin: A Case Report. J Addict Med. 2017 Jan/Feb; 11(1):77-79. PMID: 28027191.
    View in: PubMed
  10. Suzuki J, El-Haddad S. A review: Fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017 02 01; 171:107-116. PMID: 28068563.
    View in: PubMed
  11. Welsh JW, Rodriguez C, Suzuki J. Bilateral Upper Extremity Cellulitis From Injecting Crack Cocaine Dissolved in Lemon Juice: A Case Report. Prim Care Companion CNS Disord. 2016 Oct 13; 18(5). PMID: 27835731.
    View in: PubMed
  12. Hardaway R, Schweitzer J, Suzuki J. Hallucinogen Use Disorders. Child Adolesc Psychiatr Clin N Am. 2016 Jul; 25(3):489-96. PMID: 27338969.
    View in: PubMed
  13. Suzuki J. Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis. Am J Addict. 2016 Apr; 25(3):191-4. PMID: 26991660.
    View in: PubMed
  14. Dwyer-Clonts M, Frates E, Suzuki J. Managing Problem Drinking: Screening Tools and Brief Interventions for Primary Care Physicians. Am J Lifestyle Med. 2017 Nov-Dec; 11(6):424-429. PMID: 30202365.
    View in: PubMed
  15. Suzuki J, Dodds T. Clinician recommendation of 12-step meeting attendance and discussion regarding disclosure of buprenorphine use among patients in office-based opioid treatment. Subst Abus. 2016; 37(1):31-4. PMID: 26682722.
    View in: PubMed
  16. Rodriguez CP, Vaidya A, Tishler LW, Suzuki J. INTERACTIVE MEDICAL CASE. A Painful Subject. N Engl J Med. 2015 Dec 24; 373(26):e32. PMID: 26699187.
    View in: PubMed
  17. Mittal L, Suzuki J. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy. Subst Abus. 2017 Jul-Sep; 38(3):261-264. PMID: 26672650.
    View in: PubMed
  18. Minen MT, Lindberg K, Wells RE, Suzuki J, Grudzen C, Balcer L, Loder E. Survey of Opioid and Barbiturate Prescriptions in Patients Attending a Tertiary Care Headache Center. Headache. 2015 Oct; 55(9):1183-91. PMID: 26316376; PMCID: PMC4757493 [Available on 10/01/16].
  19. Shu J, Huang H, Suzuki J. The Early-Career Consultation Psychiatrist: Leading the Integration of Substance Use Treatment Into the Primary Care Setting. Psychosomatics. 2015 Nov-Dec; 56(6):706-7. PMID: 26674483.
    View in: PubMed
  20. Suzuki J, Ellison TV, Connery HS, Surber C, Renner JA. Training in Buprenorphine and Office-Based Opioid Treatment: A Survey of Psychiatry Residency Training Programs. Acad Psychiatry. 2016 Jun; 40(3):498-502. PMID: 26017618.
    View in: PubMed
  21. Sivashanker K, Mufson M, Mittal L, Ross E, Suzuki J. Challenges in managing acute on chronic pain in a pregnant woman at high risk for opioid use disorder in the general hospital setting. Harv Rev Psychiatry. 2015 Mar-Apr; 23(2):157-66. PMID: 25747928.
    View in: PubMed
  22. Suzuki J, Zinser J, Klaiber B, Hannon M, Grassi H, Spinosa M, Ramirez A, Issa M, Chin Feman SP. Feasibility of Implementing Shared Medical Appointments (SMAs) for Office-Based Opioid Treatment With Buprenorphine: A Pilot Study. Subst Abus. 2015; 36(2):166-9. PMID: 25738320.
    View in: PubMed
  23. Suzuki J, DeVido J, Kalra I, Mittal L, Shah S, Zinser J, Weiss RD. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series. Am J Addict. 2014 Nov 06. PMID: 25376754.
    View in: PubMed
  24. Suzuki J, Dekker MA, Valenti ES, Arbelo Cruz FA, Correa AM, Poklis JL, Poklis A. Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature. Psychosomatics. 2015 Mar-Apr; 56(2):129-39. PMID: 25659919; PMCID: PMC4355190.
  25. Suzuki J, Poklis JL, Poklis A. "My friend said it was good LSD": a suicide attempt following analytically confirmed 25I-NBOMe ingestion. J Psychoactive Drugs. 2014 Nov-Dec; 46(5):379-82. PMID: 25364988; PMCID: PMC4220298.
  26. Suzuki J, Connery HS, Ellison TV, Renner JA. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency. Am J Addict. 2014 Nov-Dec; 23(6):618-22. PMID: 25065457; PMCID: PMC4391742.
  27. Suzuki J, Matthews ML, Brick D, Nguyen MT, Wasan AD, Jamison RN, Ellner AL, Tishler LW, Weiss RD. Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically. J Opioid Manag. 2014 May-Jun; 10(3):159-68. PMID: 24944066; PMCID: PMC4085743.
  28. Huang H, Chan YF, Bauer AM, Suzuki J, Katon W, Russo J, Hogan D, Unützer J. Specialty behavioral health service use among chronically ill medicare advantage patients with substance use problems. Psychosomatics. 2013 Nov-Dec; 54(6):546-51. PMID: 23932530; PMCID: PMC3830673.
  29. Isomura T, Suzuki J, Murai T. Paradise Lost: The relationships between neurological and psychological changes in nicotine-dependent patients. Addict Res Theory. 2014 Apr; 22(2):158-165. PMID: 24719610.
    View in: PubMed
  30. Suzuki J, Meyer F, Wasan AD. Characteristics of medical inpatients with acute pain and suspected non-medical use of opioids. Am J Addict. 2013 Sep-Oct; 22(5):515-20. PMID: 23952900.
    View in: PubMed
  31. Suzuki J, Mittal L, Woo SB. Sublingual buprenorphine and dental problems: a case series. Prim Care Companion CNS Disord. 2013; 15(5). PMID: 24511440; PMCID: PMC3907320.
  32. Suzuki J, Park EM. Buprenorphine/naloxone and dental caries: a case report. Am J Addict. 2012 Sep-Oct; 21(5):494-5. PMID: 22882403.
    View in: PubMed
  33. Park EM, Meltzer-Brody S, Suzuki J. Evaluation and management of opioid dependence in pregnancy. Psychosomatics. 2012 Sep-Oct; 53(5):424-32. PMID: 22902085.
    View in: PubMed
  34. Freedman JL, Crow FF, Gutheil TG, Sanchez LT, Suzuki J. Treating a physician patient with psychosis. Asian J Psychiatr. 2012 Jun; 5(2):193-8. PMID: 22813669.
    View in: PubMed
  35. Park EM, Suzuki J. Treatment of opioid dependence and cancer pain with sublingual buprenorphine: a case report. Am J Addict. 2012 May-Jun; 21(3):283-4. PMID: 22494234.
    View in: PubMed
  36. Suzuki J, Haimovici F, Chang G. Alcohol use disorders after bariatric surgery. Obes Surg. 2012 Feb; 22(2):201-7. PMID: 21188544.
    View in: PubMed
  37. Suzuki J, Chang G. Consultation to the medically ill: a survey of addiction psychiatry fellowship programs. Am J Addict. 2011 Sep-Oct; 20(5):476-7. PMID: 21838848; PMCID: PMC3156615.
  38. Suzuki J, Gitlin DF, Chang G. Survey of psychosomatic medicine fellowships: training in substance use disorders. Psychosomatics. 2011 May-Jun; 52(3):296-7. PMID: 21565606.
    View in: PubMed
  39. Suzuki J, Tyson JW. Misconceptions about the safety of ingesting methanol-based solid fuels: a case report. Prim Care Companion CNS Disord. 2011; 13(2). PMID: 21977352; PMCID: PMC3184589.
  40. Halpern JH, Suzuki J, Huertas PE, Passie T. Addiction Medicine: Science and Practice. Edited by Johnson BA. Hallucinogens. 2010; p1083-98.
  41. Renner JA & Suzuki J. Addiction Medicine: Science and Practice. Edited by Johnson BA. Opiates and prescription drugs. 2010; p463-94.
  42. Suzuki J. Handbook of office-based buprenorphine treatment of opioid dependence. Edited by Renner JA, Levounis P. Logistics of office-based opioid treatment with buprenorphine. 2010; pp 253-274.
  43. Halpern JH, Suzuki J, Huertas PE, Passie T. Encyclopedia of Psychopharmacology. Edited by Stolerman IP. Hallucinogen abuse and dependence. 2010; pp569-572.
  44. Suzuki J, Halpern JH, Passie T, Huertas PE. Pharmacology and Treatment of Substance Abuse: Evidence- and Outcome-Based Perspectives. Edited by Cohen LM, Collins FL, Young AM, McChargue DE, Leffingwell TR, Cook KL. Hallucinogens. 2009; pp319-418.
  45. Van Der Kolk BA, Burbridge JA, Suzuki J. The psychobiology of traumatic memory. Clinical implications of neuroimaging studies. Ann N Y Acad Sci. 1997 Jun 21; 821:99-113. PMID: 9238197.
    View in: PubMed
  46. van der Kolk BA, Burbridge JA, Suzuki J. Acta Neuropsychiatrica. Current status on the psychobiology of posttraumatic stress disorder. 1995; 7(S):34-37.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Suzuki's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (126)
Explore
_
Co-Authors (33)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Tool Page Footer - Harvard Catalyst Tool Page Footer – Harvard Catalyst
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.